Neoprobe responds to FDA on Lymphoseek
This article was originally published in Clinica
Executive Summary
In a bid to end a US FDA-sanctioned clinical hold of multicentre trials of its lymphatic tissue-tracing agent, Neoprobe has submitted with the agency information requested on the product.